STN-1014100
- Generic Name
- STN-1014100
Relative Bioavailability of Olodaterol and Fluconazole
Phase 1
Completed
- Conditions
- HealthyPulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2014-06-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 35
- Registration Number
- NCT01153724
- Locations
- 🇩🇪
1222.48.1 Boehringer Ingelheim Investigational Site, Berlin, Germany
Relative Bioavailability of of Olodaterol and Ketoconazole
Phase 1
Completed
- Conditions
- HealthyPulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 32
- Registration Number
- NCT01153711
- Locations
- 🇩🇪
1222.47.1 Boehringer Ingelheim Investigational Site, Ingelheim, Germany
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
Phase 3
Completed
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 99
- Registration Number
- NCT00931385
- Locations
- 🇺🇸
1222.24.24009 Boehringer Ingelheim Investigational Site, Overland Park, Kansas, United States
🇺🇸1222.24.24002 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States
🇺🇸1222.24.24010 Boehringer Ingelheim Investigational Site, Oklahoma City, Oklahoma, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath